Immune Repertoire Sequencing Market Size & Share, by Product Type (Instruments, Assay Kits); Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development, Efficacy, Transplant Rejection, Tolerance, Infectious Diseases); End-user (Pharmaceutical Companies, Research Institutes, Diagnostic Labs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

Growth Drivers

• Increasing Number of Launches of Novel Products – Escalating number of launches of novel products and a growing number of research and development activities carried out by key market players are estimated to propel the market demand in the predicted period. In order to characterize human B cells a company named ArcherDX launched Archer Immunoverse B cell Receptor assays in 2017. As per a Cold Spring Harbour Laboratory study, Stanford University researchers used immune repertoire sequencing to recognize the disease-associated symptom in the immune system of patients suffering from an autoimmune disease named systemic sclerosis-related pulmonary disease.
• Rising Government Funding to Improve the Healthcare Infrastructure – Governments of various regions are offering investments and funding in order to improve the healthcare infrastructure all across the globe, which further boosts the growth of this market. As immune repertoire sequencing plays a vital role in a couple of therapeutic areas.
• High Demand for Personalized Medicines - Rising demand for personalized medicine is expected to have a positive impact on the growth of the global immune repertoire sequencing market. Moreover, promoting the role of next-generation immune repertoire sequencing for personalized immune regulation is expected to surely support the market growth. 

Challenges

• Accuracy Differences and Partial Techniques Utilization - Distinguishing biological changes from errors and biases introduced at various stages is a challenge in immune repertoire sequencing. Conventional and new bioinformatics techniques such as high-throughput screening and Haystack heuristics fall short due to their poor scalability and sensitivity and their limitations in providing sufficient and reliable data. Moreover, inconsistencies in data acquisition and processing in different laboratories, and barriers in immune repertoire sequencing systems are some of the significant reasons that may limit the growth of the immune repertoire sequencing market. 
• Lack of Skilled Personnel in Lower Economic Regions
• Discrepancies in Data Collection